Repositrak's Q2 revenue rises 7%, EPS up 13%

Reuters
Feb 18
Repositrak's <a href="https://laohu8.com/S/QTWO">Q2</a> revenue rises 7%, EPS up 13%

Overview

  • Food traceability network's fiscal Q2 revenue rose 7% yr/yr to $5.9 mln

  • EPS for fiscal Q2 increased 13% to $0.09 per share

  • Company repurchased 79,927 common shares for $1.1 mln

Outlook

  • Company did not provide specific guidance for future quarters or full year

Result Drivers

  • TRACEABILITY DEMAND - Increased demand for traceability solutions among smaller ingredient providers drove revenue growth

  • TOUCHLESS TRACEABILITY - Development of Touchless Traceability technology expected to enhance efficiency and competitive advantage

  • OPERATING EXPENSES - Reduced operating expenses contributed to higher operating income

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$5.90 mln

$5.77 mln (1 Analyst)

Q2 EPS

Meet

$0.09

$0.09 (1 Analyst)

Q2 Net Income

$1.60 mln

Q2 Dividend

$0.02

Q2 Operating Expenses

$4 mln

Q2 Operating Income

$1.80 mln

Analyst Coverage

  • The one available analyst rating on the shares is "buy"

  • The average consensus recommendation for the software peer group is "buy"

  • Wall Street's median 12-month price target for ReposiTrak Inc is $29.00, about 181.8% above its February 13 closing price of $10.29

  • The stock recently traded at 23 times the next 12-month earnings vs. a P/E of 33 three months ago

Press Release: ID:nBw76HWZma

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10